Option Care Health (NASDAQ:OPCH) Releases Quarterly Earnings Results, Beats Expectations By $0.04 EPS

Option Care Health (NASDAQ:OPCH) issued its quarterly earnings data on Tuesday. The company reported $0.26 EPS for the quarter, topping the consensus estimate of $0.22 by $0.04, Briefing.com reports. Option Care Health had a return on equity of 18.92% and a net margin of 6.15%. The company had revenue of $1.15 billion during the quarter, compared to analyst estimates of $1.10 billion. During the same quarter in the previous year, the company posted $0.21 earnings per share. Option Care Health’s revenue was up 12.8% compared to the same quarter last year. Option Care Health updated its FY 2024 guidance to EPS.

Option Care Health Stock Performance

NASDAQ:OPCH opened at $29.93 on Thursday. The stock has a 50-day simple moving average of $32.13 and a two-hundred day simple moving average of $31.52. Option Care Health has a 52-week low of $24.23 and a 52-week high of $35.74. The company has a debt-to-equity ratio of 0.74, a quick ratio of 1.33 and a current ratio of 1.77. The firm has a market capitalization of $5.20 billion, a PE ratio of 19.69, a P/E/G ratio of 1.74 and a beta of 1.22.

Insider Buying and Selling at Option Care Health

In related news, Director Harry M. Jansen Kraemer, Jr. purchased 35,000 shares of the business’s stock in a transaction on Monday, February 26th. The stock was acquired at an average price of $31.55 per share, with a total value of $1,104,250.00. Following the completion of the acquisition, the director now owns 269,528 shares of the company’s stock, valued at approximately $8,503,608.40. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. 0.64% of the stock is currently owned by corporate insiders.

Analysts Set New Price Targets

Several analysts recently commented on the company. Jefferies Financial Group lifted their price objective on Option Care Health from $36.00 to $38.00 and gave the stock a “buy” rating in a report on Monday, March 4th. Barrington Research reaffirmed an “outperform” rating and issued a $38.00 price objective on shares of Option Care Health in a report on Wednesday.

Option Care Health Company Profile

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.